Skip to main content

Andrew Kruse

NIH Rank #856
  • Top 5% Funded
  • R01 Holder
  • Translational
  • Multi-Institutional
  • Early Career

Researcher identity and coverage

Current affiliation
Not verified in ScienceDex.NIH award organizations may differ from a researcher's employer.
NIH RePORTER identity
Profile ID 10334335Search this ID in NIH RePORTER
ScienceDex PI coverage
FY2024 through FY2026Career claims are limited to the years shown.

FY2026 award categories

  • Biomedical Engineering
  • Microbiology & Immunology
  • CHEMISTRY
  • Biochemistry

NIH Funding · FY2024

Linked Award Amount
$5.9M
Full award amounts, FY2024
Award Records
7
Records listing this PI
Award-Linked Rank
#856
By linked amount among FY2024 PIs
Earliest Year Loaded
2024
ScienceDex PI coverage

One scientist record

NIH portfolios and SHARE

This is the common ScienceDex page for Andrew Kruse. NIH portfolio memberships are contextual views of this scientist, while SHARE Score, S-Index, and S-Impact describe the researcher's global sharing track record.

Review metric definitions

FY2024 NIH portfolio memberships

No institute-level portfolio release is available for this scientist and fiscal year yet. Existing award history remains unchanged above.

Researcher-associated datasets

These datasets are linked to this researcher's ShareScore identity. This does not by itself prove that an NIH portfolio funded each dataset.

No compatible author-to-dataset release is published. Dataset records are unavailable, not zero.

Award-linked funding history

Linked NIH award amounts and rank by fiscal year.

FY2024 award records by amount

NIH award records listing Andrew Kruse as a PI. Multi-PI records show the full award amount for context.

  • 5R01CA260415-05R01
    Making antibody generation rapid, scalable, and democratic through machine learning and continuous evolution
    $1.7M
    award amount
  • 5R01AI164647-03R01
    Molecular basis of spore germination
    $847.2K
    award amount
  • 5U19AI158028-03U19
    Exploiting membrane targets to overcome antibiotic resistance
    $732.3K
    award amount
  • 5R01AI153358-05R01
    Targeting Membrane Transport Steps in Cell Envelope Assembly
    $726.7K
    award amount
  • 1R01NS131463-01A1R01
    Mechanisms of Regulation of Neuronal GPCRs by KCTDs
    $676.8K
    award amount
  • 5R01AR081264-03R01
    The Conundrum of Absentee Receptors: Efficacy Potentiation Through Drug-Receptor Modulation
    $629K
    award amount
  • 5R01AR079489-03R01
    Sustained Release Relaxin-2 for the Treatment of Frozen Shoulder
    $603.7K
    award amount

Coverage and award-record milestones

Computed from the fiscal years currently available in ScienceDex.

  1. 2024
    First NIH Award
    University of California-Irvine
  2. 2024
    $500K Cumulative Funding
  3. 2024
    $1M Cumulative Funding
  4. 2024
    $2M Cumulative Funding
  5. 2024
    $5M Cumulative Funding
  6. 2024
    Entered Top 50% Nationally
    Ranked #856
  7. 2024
    Entered Top 25% Nationally
    Ranked #856
  8. 2024
    Entered Top 10% Nationally
    Ranked #856
  9. 2024
    Entered Top 5% Nationally
    Ranked #856
  10. 2025
    $10M Cumulative Funding
  11. 2025
    Multi-Institutional Research
    Awards at 5 institutions
  12. 2025
    R01 Grant Holder
Andrew Kruse | NIH Award Records | ConductScience